Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report

Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report

BackgroundImmune checkpoint inhibitors deeply modified metastatic renal cell carcinoma’s management, and confront us to adverse events that we were not used to with conventional anti-cancer therapies. We report the case of a patient who received nivolumab as second-line treatment of a metastatic cle...

Full description

Bibliographic Details
Main Authors: Roxane Mari, Mathilde Guerin, Cécile Vicier, Jochen Walz, Nathalie Bonnet, Géraldine Pignot, Gwenaelle Gravis
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
renal cell carcinoma
immunotherapy
bullous pemphigoid
durable response
late adverse event
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.984132/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.984132/full

Similar Items